Carissa C. W. Wong

Carissa C. W. Wong

Auto-generated profile, based on publicly available information

Carissa C. W. Wong

School of Cellular and Molecular Medicine, University of Bristol, Bristol BS8 1TD, UK

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 September 2025 in Science Signaling
Verified
Journal Article
Closed access
HAHanin Alamir
Hanin Alamir
CWCarissa C. W. Wong
Carissa C. W. Wong
AAAmal Alsubaiti
Amal Alsubaiti
GEGrace Edmunds
Grace Edmunds
MAMaryam Alismail
Maryam Alismail
CWChristoph Wulfing
Christoph Wulfing
TIM3 is a coregulatory receptor that is highly abundant on multiple immune cell types, including T cells in response to prolonged exposure to antigen, and it marks functionally suppressed cytotoxic T lymphocytes (CTLs) in the tumor microenvironment. TIM3 exhibits inhibitory function in vivo but paradoxically has costimulatory T cell signaling capability in vitro. Here, we found that TIM3 directly inhibited the function of murine and human CTLs in direct interaction with target tumor cell spheroids. TIM3 regulated the ability of suppressed CTLs to polarize their actin cytoskeleton as a required step in cytolysis. Whereas the expression of the proposed TIM3 ligands CEACAM1 and galectin 9 in trans on target tumor cells enhanced TIM3 function, expression of CEACAM1 in cis on CTLs had the opposite effect. TIM3 functioned as an inhibitory receptor on spheroid-suppressed CTLs but not on active CTLs in a two-dimensional tissue culture model. Together, these data suggest that TIM3 enhances T cell function, serving as either a coinhibitory or costimulatory receptor depending on the functional context of the T cell on which it is expressed.